Deschloroclozapine exhibits an exquisite agonistic effect at lower concentration compared to clozapine-N-oxide in hM3Dq expressing chemogenetically modified rats

IntroductionWithin the realm of chemogenetics, a particular form of agonists targeting designer receptors exclusively activated by designer drugs (DREADDs) has emerged. Deschloroclozapine (DCZ), a recently introduced DREADDs agonist, demonstrates remarkable potency in activating targeted neurons at...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Makiko Shimizu, Mitsuhiro Yoshimura, Kazuhiko Baba, Naofumi Ikeda, Yuki Nonaka, Takashi Maruyama, Tatsushi Onaka, Yoichi Ueta
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2023-11-01
Serie:	Frontiers in Neuroscience
Soggetti:	deschloroclozapine clozapine-N-oxide DREADDs oxytocin central nervous system Fos
Accesso online:	https://www.frontiersin.org/articles/10.3389/fnins.2023.1301515/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!